NR2C1 - nuclear receptor subfamily 2 group C member 1 Gene
Also Known as TR2
Species: Homo sapiens
About NR2C1
This gene has 19 transcripts (splice variants), 233 orthologues and 11 paralogues. Ubiquitous expression in testis (RPKM 8.3), endometrium (RPKM 5.9) and 25 other tissues.
Summary
This gene encodes a nuclear hormone receptor characterized by a highly conserved DNA binding domain (DBD), a variable hinge region, and a carboxy-terminal ligand binding domain (LBD) that is typical for all members of the steroid/Thyroid Hormone Receptor superfamily. This protein also belongs to a large family of ligand-inducible transcription factors that regulate gene expression by binding to specific DNA sequences within promoters of target genes. Multiple alternatively spliced transcript variants have been described, but the full-length nature of some of these variants has not been determined. [provided by RefSeq, Jul 2008]
NR2C1 Products (3)
| mRNA | Protein | Name |
|---|---|---|
| NM_001032287.3 | NP_001027458.1 | nuclear receptor subfamily 2 group C member 1 isoform b |
| NM_001127362.2 | NP_001120834.1 | nuclear receptor subfamily 2 group C member 1 isoform c |
| NM_003297.4 | NP_003288.2 | nuclear receptor subfamily 2 group C member 1 isoform a |
NR2C1 Protein Structure
zf-C4: Zinc finger, C4 type (two domains) (112 - 180)
Hormone_recep: Ligand-binding domain of nuclear hormone receptor (381 - 573)
- 0
- 100
- 200
- 300
- 400
- 500
- 603 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
nuclear receptor subfamily 2 group C member 1 |
|
Related Diseases
| Diseases | Alias | |
|---|---|---|
| Fanconi Anemia, Complementation Group A |
|
|
Orthologs Information
| Species | Symbol | Source | ID |
|---|---|---|---|
| Macaca mulatta | NR2C1 | VGNC | VGNC:75508 |
| Rattus norvegicus | NR2C1 | RGD | RGD:3200 |
| Felis catus | NR2C1 | VGNC | VGNC:68548 |
| Mus musculus | NR2C1 | MGD | MGI:1352465 |
| Canis familiaris | NR2C1 | VGNC | VGNC:43946 |
| Bos taurus | NR2C1 | VGNC | VGNC:32235 |
| Others | NR2C1 | NCBI |